Bavarian Nordic Completes Enrollment of Phase 3 Lot-Consistency Trial of Freeze-dried Smallpox Vaccine

NASDAQ Market News November 11, 2019

NASDAQ Market News
Click here to email author

Oasmia resolves on a rights issue of approximately SEK 399 million

Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone

Ads